Brace Yourselves SURPASS CVOT

Quote

















Not one single positive leak on this trial on this forum, It is not going to be good and you also have the Hit Job from the same group that took down Avandia at the ADA this June. The Emulated Surpass-CVOT is funded by the Cleveland Clinic, my guess they are trying to take down our great Mounjaro product. It is sad really!
 


anonymous said:
Not one single positive leak on this trial on this forum, It is not going to be good and you also have the Hit Job from the same group that took down Avandia at the ADA this June. The Emulated Surpass-CVOT is funded by the Cleveland Clinic, my guess they are trying to take down our great Mounjaro product. It is sad really!
Click to expand...
No it is not funded by the Cleveland Clinic, although Steve Nissen is listed an an author on one of the publications. BWH is the sponsor. Explain where you are getting this.
 


anonymous said:
No it is not funded by the Cleveland Clinic, although Steve Nissen is listed an an author on one of the publications. BWH is the sponsor. Explain where you are getting this.
Click to expand...
You are right it is actually sponsored by

Collaborators and Investigators​

This is where you will find people and organizations involved with this study.
Sponsor
Brigham and Women's Hospital
 










Insider Here, Unfortunately because of forced titration from 5mg, then 10 mg, then 15mg, there were more CV events early in Active Arm of the trial. We did not have the the in-between doses which would have helped. The data will be released toward the end of June.
 




anonymous said:
Why does that matter?
Click to expand...
nothing matters if you read it on here pure and simple. while I believe Cafe Pharma is a place where there are grains of truth when it comes to company downsizing or people ranting. it cannot be trusted when it comes to unknown study results. you cannot police on here when its the competition conducting PSYOPS. So at the end of the day, the Surpass-CVOT results will be released soon and we will know the truth and compare it to what was "leaked" here (if anything were really leaks to begin with). So to the 120k people who are following this thread, as far as I am concerned all of what we read here is meaningless.
 


anonymous said:
nothing matters if you read it on here pure and simple. while I believe Cafe Pharma is a place where there are grains of truth when it comes to company downsizing or people ranting. it cannot be trusted when it comes to unknown study results. you cannot police on here when its the competition conducting PSYOPS. So at the end of the day, the Surpass-CVOT results will be released soon and we will know the truth and compare it to what was "leaked" here (if anything were really leaks to begin with). So to the 120k people who are following this thread, as far as I am concerned all of what we read here is meaningless.
Click to expand...
Grains of truth. LOL
 


anonymous said:
nothing matters if you read it on here pure and simple. while I believe Cafe Pharma is a place where there are grains of truth when it comes to company downsizing or people ranting. it cannot be trusted when it comes to unknown study results. you cannot police on here when its the competition conducting PSYOPS. So at the end of the day, the Surpass-CVOT results will be released soon and we will know the truth and compare it to what was "leaked" here (if anything were really leaks to begin with). So to the 120k people who are following this thread, as far as I am concerned all of what we read here is meaningless.
Click to expand...
Exactly, Cafepharma is the place I go to remind myself of why I left Lilly, how awful the culture is there. But not for commentary on a double blind clinical study, especially when posters pretending to be experts don't even have the basic facts straight. Such as...

SURPASS CVOT is not being presented at ADA in June, all you have to do is look at Lilly's press releases to see that. Will be sometime in 2025, but not ADA unless it is a late breaker. It's more likely some other meeting later this year.

What is being presented at ADA is an "emulated" SURPASS CVOT. This is the study run out of BWH. From the literature, "this new user active comparator cohort study aims to emulate the SURPASS CVOT trial using insurance claims data." It's an RWE study, and rarely do these move markets. And even this study is blinded to the investigators, they don't get to sit and watch the events accrue in each arm.

Who knows, maybe the data will be great, maybe not. But be suspicious of anyone who claims to have special insider knowledge.
 



Write your reply...
Top Bottom
Back
Quote